Results for tag: "Staphylococcus Aureus Drug"

The Staphylococcus Aureus Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat infections caused by the Staphylococcus Aureus bacteria, which is a common cause of skin and respiratory infections. These drugs are typically antibiotics, such as penicillin, cephalosporins, and vancomycin, as well as newer agents such as linezolid and daptomycin. These drugs are used to treat a variety of infections, including skin and soft tissue infections, endocarditis, and sepsis. The Staphylococcus Aureus Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bayer. Show Less Read more